Processa Pharmaceuticals, Inc. PCSA Q1 2026 Annual earnings
Reported May 7, 2026 · After market close
EPS-$1.29Miss by $0.29
EPS estimate-$1.00
Next report
Aug 6, 2026 (In 1 week)EPS estimate-$1.00
Versus estimates
Diluted EPS
Ask the moment Processa Pharmaceuticals, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Processa Pharmaceuticals, Inc. report Q1 2026 earnings?
- Processa Pharmaceuticals, Inc. (PCSA) reported Q1 2026 earnings on May 7, 2026 after market close.
- What were Processa Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
- Processa Pharmaceuticals, Inc. reported eps of $-1.29 for Q1 2026.
- Did Processa Pharmaceuticals, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-1.00 by $0.29.
- How did Processa Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 330.0% from $-0.30.
- Where can I find Processa Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
- You can read the 10-K/A periodic report (0001493152-26-020731) directly on SEC EDGAR. The filing index links above go to sec.gov.